Agenus Presents Biomarker Data Demonstrating Survival Stratification in MSS mCRC and Other Immunologically Cold Tumors Treated with BOT+BAL Agenus Inc. a leader in immuno-oncology, today announced new translational and clinical…
New Case Study Highlights Ability of bioAffinity Technologies’ CyPath® Lung to Reduce Diagnostic Burden for Patients At Risk for Lung Cancer bioAffinity Technologies, Inc. a biotechnology company advancing noninvasive diagnostics for…
Worldwide Clinical Trials Completes Acquisition of Catalyst Clinical Research Worldwide Clinical Trials a global contract research organization (CRO), has completed its acquisition of Catalyst Clinical Research, LCC (“Catalyst”) – a specialized oncology CRO and…
Zeon Corporation Makes Strategic Investment in Chemify to Accelerate Digital Chemistry Innovation and Drive Development of New Materials Through State-of-the-Art Automated Molecular Design and Synthesis Zeon Corporation (Zeon; head office:…
Legends of Basketball Partners with Prostate Cancer Foundation on “Check the Box!” New National Prostate Cancer Awareness Initiative The Prostate Cancer Foundation (PCF) and the Legends of Basketball / National Basketball Retired Players Association (NBRPA) today…
Ethris and German Center for Infection Research (DZIF) Announce Strategic Collaboration to Develop mRNA-Based Vaccines Ethris GmbH, a clinical-stage biotechnology company pioneering next-generation RNA therapeutics and vaccines, and the German Center…
Eurofins Viracor BioPharma Expands Bioanalytical Capabilities Eurofins Viracor BioPharma Services, a long‑standing and trusted partner for clinical trial testing solutions with deep expertise in specialty biomarkers and molecular assays, announces…
restor3d Announces Full Commercial Launch of Ossera™ AFX Ankle Fusion Cage System, Immediately Available in Both Standard and Made-to-Order Options restor3d, a leader in 3D-printed, personalized orthopedic solutions, today announced…
SynGenSys Introduces Liver.SET Synthetic Promoter Library for Liver-specific Gene Expression for in vivo Gene Therapies SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and…
CorriXR Therapeutics Publishes Peer-Reviewed Preclinical Study Demonstrating CRISPR-Based NRF2 Editing Restores Chemosensitivity in Treatment-Resistant Solid Tumors CorriXR Therapeutics, an oncology-focused biotherapeutics company developing next-generation genetic medicines to overcome drug resistance…
CareDx Announces Publication of Third SHORE Study in JHLT, Demonstrating the Strong Prognostic Value of HeartCare for Heart Transplant Recipients CareDx, Inc., a pioneer in precision medicine dedicated to improving…
St. Jude and ALSAC welcome new board members whose diverse experience will help advance research, treatment, and global impact. St. Jude Children’s Research Hospital® and ALSAC—the organization dedicated to fundraising…